← Back to Search

Other

APX-115 for COVID-19

Phase 2
Waitlist Available
Research Sponsored by Aptabio Therapeutics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up days 1, 5, and 14
Awards & highlights

Study Summary

This trial is testing a new drug to see if it is safe and effective in treating people with mild to moderate COVID-19.

Eligible Conditions
  • COVID-19
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~days 1, 5, and 14
This trial's timeline: 3 weeks for screening, Varies for treatment, and days 1, 5, and 14 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of Treatment-Emergent Adverse Events
Secondary outcome measures
AUC within a dosing interval (AUCtau, where tau = 12 hours)
Area under the plasma concentration versus time curve (AUC) from time zero to the Time of last quantifiable concentration (AUC0-last)
Change in log10 SARS-CoV-2 viral load
+12 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: APX-115Experimental Treatment1 Intervention
Oral administration of APX-115 100mg, daily for 14 days
Group II: PlaceboPlacebo Group1 Intervention
Oral administration of Placebo, daily for 14 days
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
APX-115
2020
Completed Phase 2
~140

Find a Location

Who is running the clinical trial?

Aptabio Therapeutics, Inc.Lead Sponsor
3 Previous Clinical Trials
508 Total Patients Enrolled
CovanceIndustry Sponsor
119 Previous Clinical Trials
12,800 Total Patients Enrolled
5 Trials studying COVID-19
1,215 Patients Enrolled for COVID-19

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can patients above the age of 20 participate in this research?

"The age range for participants in this study is 18 to 80 years old."

Answered by AI

How many participants are researchers hoping to enroll in this trial?

"In order for this clinical trial to commence, 80 individuals who match the pre-determined inclusion criteria must sign-up. Alternative Research Associates, LLC in Hialeah, Florida and Anne Arundel Medical Center in Baltimore, Maryland are two of the many sites where patients can participate."

Answered by AI

What is the federal government's stance on APX-115?

"While there is some safety data for APX-115, it only received a 2 because there are no efficacy data at this time."

Answered by AI

How can I sign up for this clinical trial?

"This clinical trial is enrolling 80 people, between the ages of 18 and 80 who have covid-19. It is required that participants also meet the following criteria: Have at least one of the following symptoms at screening: fever, cough, shortness of breath, myalgia, ageusia, anosmia, fatigue, or weakness., Hospitalized with COVID-19 disease (WHO COVID-19 Clinical Improvement Ordinal Scale score of 3 [hospitalized, no oxygen therapy], 4 [hospitalized, oxygen by mask or nasal prongs], or 5 [high-flow oxygen or non-invasive mechanical ventilation]),"

Answered by AI

Are we still looking for individuals to participate in this research project?

"This clinical trial, which was first posted on October 20th 2021, is currently looking for participants."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
A Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19.
2021. "A Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04880109.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top